Exhibitors

Become An Exhibitor

You are cordially invited to become an exhibitor of the 19th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC).

We offer Exhibit space to expand your company’s appreciation, and to expose your products, and services to nearly 1,500 health care professionals who attend the annual meeting, online.


WCIRDC is committed to giving exhibitors the best value for their participation.

The 19th Annual WCIRDC is an excellent opportunity to meet with globally-recognized medical leaders, clinicians, and scientists who present and share their knowledge. The WCIRDC is designed to evaluate both clinical and basic science aspects of insulin resistance, obesity, diabetes, and CVD.

The WCIRDC achieves a great balance between clinical practice and research, by utilizing a state of the art approach: “Exploring New Frontiers in Metabolism – Tomorrow’s Clinical Science Today!”  The WCIRDC will dedicate an area, separate from the educational program, where your company will be able to exhibit products, equipment, and services.

 

2021 Exhibitor Levels

19wcirdc exhibit levels.PNG
2021 Exhibitor Prospectus/Application:  

2020 Exhibitors

AstraZeneca

Esperion

Amarin

Abbott

Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA

Novartis

Novo Nordisk

19th World Congress Insulin Resistance, DM & CVD

5th Heart in Diabetes

American Society for Preventive Cardiology (ASPC)

2019 Exhibitors

Abbott

Amarin

Amgen

AstraZeneca

Boehringer Ingelheim / Lilly USA

Corcept Therapeutics

EMK Medical Services

Janssen

Lexicon

Lilly

Mediknox

Novo Nordisk

Pharmatech

Salix

Sanofi

VeroScience